Since we demonstrated that combined inhibition with 1,4‐DPCA and SP600125 abrogated CHDH‐mediated CRC cell migration in vitro, we next validated these results in a xenograft mouse model in vivo. The gene discussed is CHDH; the disease is colorectal carcinoma.